Drug
Azd-1305 clinical trials
Also written AZD1305.
- studies test it
- 13
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
- AZD1305
- 13
Studies by the year they started
13 studies that test it; most in 2008 (9)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 9 |
| 2009 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses azd-1305 is read from its arms, and is right about nine times in ten.
Testing it · 13
- Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305CompletedPhase 2AstraZenecaNCT00915356Written as AZD1305
- Explorative Study of AZD1305 in Atrial Fibrillation PatientsCompletedPhase 2AstraZenecaNCT00643448Written as AZD1305
- Cardiac Electrophysiological StudyCompletedPhase 2AstraZenecaNCT00616629Written as AZD1305
- Investigate the Effect of AZD1305 on Patients With Left Ventricular DysfunctionCompletedPhase 2AstraZenecaNCT00748982Written as AZD1305
- AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian SubjectsTerminatedPhase 1AstraZenecaNCT00935025Written as AZD1305
- An Interaction Study With Digoxin and AZD1305CompletedPhase 1AstraZenecaNCT00712465Written as AZD1305
- Study of an Extended Release (ER) Tablet, Single and Repeated DosingCompletedPhase 1AstraZenecaNCT00689039Written as AZD1305
- Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305CompletedPhase 1AstraZenecaNCT00689403Written as AZD1305
- To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305CompletedPhase 1AstraZenecaNCT00689247Written as AZD1305
- An Interaction Study of Ketoconazole/Verapamil Versus AZD1305CompletedPhase 1AstraZenecaNCT00707551Written as AZD1305
- Single Ascending Dose Study (SAD) iv FormulationCompletedPhase 1AstraZenecaNCT00688831Written as AZD1305
- Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305CompletedPhase 1AstraZenecaNCT00957437Written as AZD1305
- To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese SubjectsCompletedPhase 1AstraZenecaNCT00738322Written as AZD1305